Eli Lilly and Company
Stock Forecast, Prediction & Price Target
Eli Lilly and Company Financial Estimates
Eli Lilly and Company Revenue Estimates
Eli Lilly and Company EBITDA Estimates
Eli Lilly and Company Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $28.31B N/A | $28.54B 0.78% | $34.12B 19.56% | Avg: $52.68B Low: $50.43B High: $55.79B avg. 54.37% | Avg: $62.25B Low: $59.50B High: $65.36B avg. 18.17% | Avg: $68.82B Low: $65.77B High: $72.26B avg. 10.54% | Avg: $79.63B Low: $76.11B High: $83.61B avg. 15.71% |
Net Income
% change YoY
| $5.58B N/A | $6.24B 11.87% | $5.24B -16.08% | Avg: $16.63B Low: $15.07B High: $18.12B avg. 217.36% | Avg: $21.43B Low: $17.69B High: $24.91B avg. 28.89% | Avg: $26.07B Low: $24.57B High: $27.76B avg. 21.62% | Avg: $31.91B Low: $30.08B High: $33.99B avg. 22.41% |
EBITDA
% change YoY
| $8.73B N/A | $9.43B 7.94% | $8.56B -9.17% | Avg: $16.97B Low: $16.25B High: $17.98B avg. 98.16% | Avg: $20.06B Low: $19.17B High: $21.06B avg. 18.17% | Avg: $22.17B Low: $21.19B High: $23.28B avg. 10.54% | Avg: $25.66B Low: $24.53B High: $26.94B avg. 15.71% |
EPS
% change YoY
| $6.15 N/A | $6.93 12.68% | $5.8 -16.30% | Avg: $18.68 Low: $16.69 High: $20.07 avg. 222.05% | Avg: $24 Low: $19.59 High: $27.58 avg. 28.48% | Avg: $28.87 Low: $27.21 High: $30.74 avg. 20.27% | Avg: $35.34 Low: $33.31 High: $37.63 avg. 22.41% |
Operating Expenses
% change YoY
| $13.45B N/A | $13.63B 1.29% | $16.71B 22.63% | Avg: $12.61B Low: $12.07B High: $13.36B avg. -24.51% | Avg: $14.91B Low: $14.25B High: $15.65B avg. 18.17% | Avg: $16.48B Low: $15.75B High: $17.30B avg. 10.54% | Avg: $19.07B Low: $18.23B High: $20.02B avg. 15.71% |
FAQ
What is Eli Lilly and Company stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 72.57% in 2025-2028.
We have gathered data from 14 analysts. Their low estimate is 15.07B, average is 16.63B and high is 18.12B.
What is Eli Lilly and Company stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 24.70% in 2025-2028.
We have gathered data from 19 analysts. Their low revenue estimate is $50.43B, average is $52.68B and high is $55.79B.
What is Eli Lilly and Company stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 73.30% in 2025-2028.
We have gathered data from 14 analysts. Their low earnings per share estimate is $16.69, average is $18.68 and high is $20.07.
What is the best performing analyst?
In the last twelve months analysts have been covering Eli Lilly and Company stock. The most successful analyst is Evan David Seigerman whose win rate is 25%. He has correctly predicted 1/4 price targets.